CASI Pharmaceuticals signs distribution deal

Rockville-based CASI Pharmaceuticals Inc. announced Wednesday the company has entered into an exclusive distribution agreement with Guokang Pharmaceuticals Co. Ltd. to be the sole distributor for the sale of its drug Evolmela in China. Evomela (melphalan hydrochloride for injection) was previously granted priority review by the National Medical Products Administration (NMPA) and subsequently approved for use ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *